Civic Intelligence

Frontiers in Bioscience Inc.

990 • Fiscal year 2021 • EIN 59-3432665

Jan 01, 2021 to Dec 31, 2021 • Filed on Sep 02, 2022

20 Sunset CoveNewport Coast, CA 92657

(949) 715-8286

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

25th percentile

0.02x

Higher debt load relative to assets than 25% of similar nonprofits.

2021 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2021

Liabilities / Revenue

78th percentile

0.66x

Higher debt load relative to revenue than 78% of similar nonprofits.

2021 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2021

Net Margin

26th percentile

1.0%

Higher net margin than 26% of similar nonprofits.

2021 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2021

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2021

Asset Growth

24th percentile

0.0%

Faster asset growth than 24% of similar nonprofits.

2021 filings • 501(c)3 • $5M-$10M nonprofits • Annualized from 2020 to 2021

Revenue Growth

2nd percentile

-76%

Faster revenue growth than 2% of similar nonprofits.

2021 filings • 501(c)3 • $5M-$10M nonprofits • Annualized from 2020 to 2021

Assets

Up

$9,156,713

Up $2,606 (+0.0%) from 2020

Net Assets

Up

$8,969,193

Up $7,339 (+0.1%) from 2020

Liabilities

Down

$187,520

Down $4,733 (-2.5%) from 2020

Revenue

Down

$284,326

Down $887,810 (-76%) from 2020

Expenses

Down

$281,359

Down $21,871 (-7.2%) from 2020

Net Income

Down

$2,967

Down $865,939 (-100%) from 2020

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$10M$5.0M$0Assets 2011: $6,072,390Liabilities 2011: $145,555Net Assets 2011: $5,926,8352011Assets 2012: $6,593,702Liabilities 2012: $161,267Net Assets 2012: $6,432,4352012Assets 2013: $7,019,430Liabilities 2013: $158,293Net Assets 2013: $6,861,1372013Assets 2014: $7,380,585Liabilities 2014: $279,146Net Assets 2014: $7,101,4392014Assets 2015: $7,717,237Liabilities 2015: $161,947Net Assets 2015: $7,555,2902015Assets 2016: $7,719,461Liabilities 2016: $139,799Net Assets 2016: $7,579,6622016Assets 2017: $7,939,484Liabilities 2017: $38,338Net Assets 2017: $7,901,1462017Assets 2018: $8,152,585Liabilities 2018: $31,140Net Assets 2018: $8,121,4452018Assets 2019: $8,329,196Liabilities 2019: $28,843Net Assets 2019: $8,300,3532019Assets 2020: $9,154,107Liabilities 2020: $192,253Net Assets 2020: $8,961,8542020Assets 2021: $9,156,713Liabilities 2021: $187,520Net Assets 2021: $8,969,1932021Assets 2021: $9,263,668Liabilities 2021: $187,520Net Assets 2021: $9,076,1482021Assets 2022: $9,068,473Liabilities 2022: $175,870Net Assets 2022: $8,892,6032022Assets 2023: $9,132,862Liabilities 2023: $252,072Net Assets 2023: $8,880,7902023Assets 2024: $9,147,259Liabilities 2024: $244,048Net Assets 2024: $8,903,2112024Assets 2025: $8,977,418Liabilities 2025: $246,462Net Assets 2025: $8,730,9562025

Highlighted filing

2021

Assets$9,156,713
Liabilities$187,520
Net Assets$8,969,193

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.5M$1.0M$500K$0-$500KExpenses 2011: $303,3232011Expenses 2012: $566,8742012Revenue 2013: $1,020,368Expenses 2013: $591,666Net Income 2013: $428,7022013Revenue 2014: $929,379Expenses 2014: $583,280Net Income 2014: $346,0992014Revenue 2015: $959,466Expenses 2015: $568,606Net Income 2015: $390,8602015Revenue 2016: $686,860Expenses 2016: $662,488Net Income 2016: $24,3722016Revenue 2017: $884,845Expenses 2017: $563,361Net Income 2017: $321,4842017Revenue 2018: $687,687Expenses 2018: $467,385Net Income 2018: $220,3022018Revenue 2019: $665,550Expenses 2019: $464,587Net Income 2019: $200,9632019Revenue 2020: $1,172,136Expenses 2020: $303,230Net Income 2020: $868,9062020Revenue 2021: $284,326Expenses 2021: $281,359Net Income 2021: $2,9672021Revenue 2021: $287,321Expenses 2021: $239,359Net Income 2021: $47,9622021Revenue 2022: $130,196Expenses 2022: $272,103Net Income 2022: -$141,9072022Revenue 2023: $252,831Expenses 2023: $264,644Net Income 2023: -$11,8132023Revenue 2024: $159,183Expenses 2024: $334,551Net Income 2024: -$175,3682024Revenue 2025: $179,746Expenses 2025: $394,681Net Income 2025: -$214,9352025

Highlighted filing

2021

Revenue$284,326
Expenses$281,359
Net Income$2,967
Jump To
Filing Snapshot
Filing Period
Jan 1, 2021 to Dec 31, 2021
Signed
Sep 2, 2022
Return Version
2021v4.0
Gross Receipts
$751,491
Mission and Program Overview

Mission

Frontiers in bioscience ia an organizatioj dedicated to fostering science, research and teaching. Fbs has been invo;ve in these activities since jan. 1 1996. Fbs has published ober 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and reurranxce as well as understanding the cause of disturbed metabolism of cancer cells in order to gain an insight to provide new avenues for treatment. We use stem cells as well as signaling molecules to acheive the therapeutic end.

Balance Sheet Detail
LineBeginningEndChange
Assets
Land, Buildings, and Equipment, Net$4,701,684$5,876,274▲ $1,174,590
Cash and Non-Interest-Bearing Accounts$4,447,763$3,280,439▼ $1,167,324
Loans From Officers Directors$155,488$154,516▼ $972
Investments in Publicly Traded Securities$4,660--
Total Assets$9,154,107$9,156,713▲ $2,606
Liabilities
Other Liabilities$36,765$33,004▼ $3,761
Total Liabilities$192,253$187,520▼ $4,733
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$8,961,854$8,969,193▲ $7,339
Total Net Assets Fund Balance$8,961,854$8,969,193▲ $7,339
Total Liabilities and Net Assets / Fund Balance$9,154,107$9,156,713▲ $2,606

Asset Categories

AssetBook ValueDepreciationBasis
Buildings$2,669,434$619,171$3,288,605
Land$3,229,805-$3,229,805
Other Land Buildings$13,169$374,660$387,829
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseTotal
Siamak Tabibzadeh MdCEOFT$88,000$88,000

Board Members and Trustees

Revenue and Support

Revenue Composition

Contributions and Grants
$0
Program Service Revenue
$286,789
Investment Income
$-23,239
Other Revenue
$20,776
Change in Net Assets
$2,967
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$150,853
Other Expenses$130,506
Total Fundraising Expense$9,463
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Comp Disqual Persons$70,400$8,800$8,800$88,000
Depreciation Depletion$50,206--$50,206
Other Salaries and Wages$50,000--$50,000
All Other Expenses$6,435$6,880-$13,315
Payroll Taxes$9,267$663$663$10,593
Other Expenses$6,142$17,519-$6,142
Insurance$4,031--$4,031
Fees for Services Accounting$3,350--$3,350
Other Employee Benefits$2,260--$2,260
Fees for Services Legal-$500-$500
Total Functional Expenses$237,534$34,362$9,463$281,359
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Insider Transactions and Loans

Loans and Receivables

Line ItemBeginningEndChange
Loans from Officers, Directors, Trustees, and Key Employees$155,488$154,516▼ $972
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Tenant Deposits$16,890
Officer Related Liability$12,925
Credit Card/ Payroll Taxes$3,189
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Backup withholding compliance
No
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
No
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Page 6, Part VI, Line 11B

No review was or will be conducted.

Form 990, Page 6, Part VI, Line 19

No documents available to the public

Filing and Contact Details

Filer

Filer Name
Frontiers in Bioscience
EIN
59-3432665
Phone
9497158286
Address
20 SUNSET COVE, NEWPORT COAST, CA 92657

Signing Officer

Name
Siamak Tabibzadeh Md
Title
CEO
Phone
9497158286
Signed
2022-09-02
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Siamak Tabibzadeh Md
Voting Board Members
3
Independent Board Members
0
Employees
3

Preparer

Firm
Lgh Consulting Inc
Address
585 S STATE COLLEGE BLVD, ANAHEIM, CA 92806-4222
Preparer
George Hukriede
Phone
7148089170
Supplemental Narrative

Additional Explanations

FORM 990 - ORGANIZATION'S MISSION

Frontiers in bioscience ia an organizatioj dedicated to fostering science, research and teaching. Fbs has been invo;ve in these activities since jan. 1 1996. Fbs has published ober 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and reurranxce as well as understanding the cause of disturbed metabolism of cancer cells in order to gain an insight to provide new avenues for treatment. We use stem cells as well as signaling molecules to acheive the therapeutic end.

Form 990

See attachment november 20, 2022 part iv, line 63, loans from officers, director and employee on november 20, 2002, frontiers in bioscience, inc. Purchased for investment purposes only residential real estate located at 67 parkview drive, searingtown, new york. In connection with the organization's purchase of said real estate, frontiers in bioscience inc., incurred a mortgage payable with the presiden and founder, siamak tabibzadeh, md, in the amount of 145,000 lender's name: siamak tabibzadeh, md original amount of note: 154,000 balance due: 145,555 date of note: november 20, 2002 maturity date: open, see below repayment terms: principal and accrued interest due upon sale of property interest rete: rate of 4.5% per annum, principal and interest due upon sale of property or at such time as the board of director determines that there are sufficient operating funds to retire the obiligation security priovided by the borrower: mortgage note secured by real estate located at 67 parkview drive, searingtown, ny 11507 purpose of the loan: to be able to purchase real estate at below fair market value to see in no longer than two operating cycles in order to obtain sufficient funding to endow a full time medical researcher and editor. Interst calcuation original amount of principal: 154,000 from to interest amount (rate, 4.5%) - principal + interest nov 20, 2002 154,000 nov 20, 2002 nov 20, 2003 6,930 - 160,930 - 15,375 removed principal & interest leaving 145,555 nov 20, 2003 nov 20, 2004 6,549 - 152,104 nov 20, 2004 nov 20, 2005 6,844 - 158,948 nov 20, 2005 nov 20, 2006 7,152 - 166,100 nov 20, 2006 nov 20, 2007 7,474 - 173,574 nov 20, 2007 nov 20, 2008 7,810 - 181,384 nov 20, 2008 nov 20, 2009 8,162 - 189,546 nov 20, 2009 nov 20, 2010 8,529 - 198,075 nov 20, 2010 nov 20, 2011 8,913 - 206,988 nov 20, 2011 nov 20, 2012 9,314 - 216,302 nov 20, 2012 nov 20, 2013 9,733 - 226,035 nov 20, 2013 nov 20, 2014 10,171 - 236,206 nov 20, 2014 nov 20, 2015 10,629 - 257,942 nov 20, 2015 nov 20, 2016 11,107 - 246,835 nov 20, 2016 nov 20, 2017 11,607 - 269,549 principal paid 269,549-145,555=123,994 nov 20, 2017 nov 20, 2018 5,579 - 129,573 nov 20, 2018 nov 20, 2019 5,830 - 135,403 nov 20, 2019 nov 20, 2020 6,093 - 141,496 nov 20, 2020 nov 20, 2021 6,367 - 147,863 nov 20, 2021 nov 20, 2022 6,653 - 154.516

Form 990, Part XI

Adjustment to beginning of value of investments -14160

Form 990, Part XI, Line 9

Book / tax depreciation difference 18,532

Raw XML Appendix346 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0FRONTIERS IN BIOSCIENCE IA AN ORGANIZATIOJ DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVO;VE IN THESE ACTIVITIES SINCE JAN. 1 1996. FBS HAS PUBLISHED OBER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND REURRANXCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM OF CANCER CELLS IN ORDER TO GAIN AN INSIGHT TO PROVIDE NEW AVENUES FOR TREATMENT. WE USE STEM CELLS AS WELL AS SIGNALING MOLECULES TO ACHEIVE THE THERAPEUTIC END.
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt06880
IRS990/AllOtherExpensesGrp/ProgramServicesAmt06435
IRS990/AllOtherExpensesGrp/TotalAmt013315
IRS990/BackupWthldComplianceInd0false
IRS990/BooksInCareOfDetail/PersonNm0SIAMAK TABIBZADEH MD
IRS990/BooksInCareOfDetail/PhoneNum09497158286
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt020 SUNSET COVE
IRS990/BooksInCareOfDetail/USAddress/CityNm0NEWPORT COAST
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd092657
IRS990/BusinessRlnWith35CtrlEntInd0false
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt04447763
IRS990/CashNonInterestBearingGrp/EOYAmt03280439
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CollectionsOfArtInd0false
IRS990/CompDisqualPersonsGrp/FundraisingAmt08800
IRS990/CompDisqualPersonsGrp/ManagementAndGeneralAmt08800
IRS990/CompDisqualPersonsGrp/ProgramServicesAmt070400
IRS990/CompDisqualPersonsGrp/TotalAmt088000
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0false
IRS990/CompensationProcessOtherInd0false
IRS990/ConflictOfInterestPolicyInd0false
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt00
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt0-23239
IRS990/CYOtherExpensesAmt0130506
IRS990/CYOtherRevenueAmt020776
IRS990/CYProgramServiceRevenueAmt0286789
IRS990/CYRevenuesLessExpensesAmt02967
IRS990/CYSalariesCompEmpBnftPaidAmt0150853
IRS990/CYTotalExpensesAmt0281359
IRS990/CYTotalFundraisingExpenseAmt09463
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0284326
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/DepreciationDepletionGrp/ProgramServicesAmt050206
IRS990/DepreciationDepletionGrp/TotalAmt050206
IRS990/Desc0FOSTERING SCIENCE, RESEARCH AND TEACHING IN THE AREAS OF MEDICINE, BIOLOGY,CANCER AND AGING.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0false
IRS990/DonorAdvisedFundInd0false
IRS990/DonorRstrOrQuasiEndowmentsInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt03
IRS990/EmploymentTaxReturnsFiledInd0true
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/ExpenseAmt0237534
IRS990/FamilyOrBusinessRlnInd0false
IRS990/FeesForServicesAccountingGrp/ProgramServicesAmt03350
IRS990/FeesForServicesAccountingGrp/TotalAmt03350
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt0500
IRS990/FeesForServicesLegalGrp/TotalAmt0500
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignOfficeInd0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt060.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/PersonNm0SIAMAK TABIBZADEH MD
IRS990/Form990PartVIISectionAGrp/PersonNm1SHILA ROOFIM
IRS990/Form990PartVIISectionAGrp/PersonNm2FOROUGH SOOFERIAN
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt088000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/TitleTxt0CEO
IRS990/Form990PartVIISectionAGrp/TitleTxt1CFO
IRS990/Form990PartVIISectionAGrp/TitleTxt2SEC
IRS990/Form990ProvidedToGvrnBodyInd0false
IRS990/Form990TFiledInd0true
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/GainOrLossGrp/SecuritiesAmt0-31667
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt03
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt0294886
IRS990/GrossReceiptsAmt0751491
IRS990/GrossRentsGrp/RealAmt0161388
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt00
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InsuranceGrp/ProgramServicesAmt04031
IRS990/InsuranceGrp/TotalAmt04031
IRS990/InvestmentIncomeGrp/ExclusionAmt08428
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt08428
IRS990/InvestmentInJointVentureInd0false
IRS990/InvestmentsPubTradedSecGrp/BOYAmt04660
IRS990/IRPDocumentCnt00
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt01029965
IRS990/LandBldgEquipBasisNetGrp/BOYAmt04701684
IRS990/LandBldgEquipBasisNetGrp/EOYAmt05876274
IRS990/LandBldgEquipCostOrOtherBssAmt06906239
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt0326553
IRS990/LessRentalExpensesGrp/RealAmt0140612
IRS990/LoanOutstandingInd0true
IRS990/LoansFromOfficersDirectorsGrp/BOYAmt0155488
IRS990/LoansFromOfficersDirectorsGrp/EOYAmt0154516
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0FRONTIERS IN BIOSCIENCE IA AN ORGANIZATIOJ DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVO;VE IN THESE ACTIVITIES SINCE JAN. 1 1996. FBS HAS PUBLISHED OBER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND REURRANXCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM OF CANCER CELLS IN ORDER TO GAIN AN INSIGHT TO PROVIDE NEW AVENUES FOR TREATMENT. WE USE STEM CELLS AS WELL AS SIGNALING MOLECULES TO ACHEIVE THE THERAPEUTIC END.
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt08961854
IRS990/NetAssetsOrFundBalancesEOYAmt08969193
IRS990/NetGainOrLossInvestmentsGrp/RelatedOrExemptFuncIncomeAmt0-31667
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt0-31667
IRS990/NetRentalIncomeOrLossGrp/TotalRevenueColumnAmt020776
IRS990/NetRentalIncomeOrLossGrp/UnrelatedBusinessRevenueAmt020776
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt08961854
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt08969193
IRS990/NondeductibleContributionsInd0false
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherChangesInNetAssetsAmt04372
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt02260
IRS990/OtherEmployeeBenefitsGrp/TotalAmt02260
IRS990/OtherExpensesGrp/Desc0LAB SUPPLIES AND FEES
IRS990/OtherExpensesGrp/Desc1UTILITIES
IRS990/OtherExpensesGrp/Desc2HOA DUES
IRS990/OtherExpensesGrp/Desc3TELEPHONE
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt017519
IRS990/OtherExpensesGrp/ProgramServicesAmt028417
IRS990/OtherExpensesGrp/ProgramServicesAmt17026
IRS990/OtherExpensesGrp/ProgramServicesAmt26142
IRS990/OtherExpensesGrp/TotalAmt028417
IRS990/OtherExpensesGrp/TotalAmt117519
IRS990/OtherExpensesGrp/TotalAmt27026
IRS990/OtherExpensesGrp/TotalAmt36142
IRS990/OtherLiabilitiesGrp/BOYAmt036765
IRS990/OtherLiabilitiesGrp/EOYAmt033004
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt050000
IRS990/OtherSalariesAndWagesGrp/TotalAmt050000
IRS990/PartialLiquidationInd0false
IRS990/PayrollTaxesGrp/FundraisingAmt0663
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt0663
IRS990/PayrollTaxesGrp/ProgramServicesAmt09267
IRS990/PayrollTaxesGrp/TotalAmt010593
IRS990/PoliticalCampaignActyInd0false
IRS990/PrincipalOfficerNm0SIAMAK TABIBZADEH MD
IRS990/ProfessionalFundraisingInd0false
IRS990/ProgramServiceRevenueGrp/BusinessCd0541700
IRS990/ProgramServiceRevenueGrp/Desc0PRODUCTS
IRS990/ProgramServiceRevenueGrp/Desc1SUBSCRIPTION FEES
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt0200305
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt186484
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt0200305
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt186484
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYExcessBenefitTransInd0false
IRS990/PYInvestmentIncomeAmt0807064
IRS990/PYOtherExpensesAmt0150122
IRS990/PYOtherRevenueAmt069365
IRS990/PYProgramServiceRevenueAmt0295707
IRS990/PYRevenuesLessExpensesAmt0868906
IRS990/PYSalariesCompEmpBnftPaidAmt0153108
IRS990/PYTotalExpensesAmt0303230
IRS990/PYTotalRevenueAmt01172136
IRS990/ReconcilationRevenueExpnssAmt02967
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/RentalIncomeOrLossGrp/RealAmt020776
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0true
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0true
IRS990/ReportProgramRelatedInvstInd0false
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt08428
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt08428
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt08428
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt0286789
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt0286789
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt08428
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt08428
IRS990ScheduleA/InvestmentIncomeCYPct00.03000
IRS990ScheduleA/InvestmentIncomePYPct00.00000
IRS990ScheduleA/NetIncomeFromOtherUBIGrp/CurrentTaxYearMinus1YearAmt017915
IRS990ScheduleA/NetIncomeFromOtherUBIGrp/TotalAmt017915
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.91590
IRS990ScheduleA/PublicSupportTotal509Amt0286789
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt0286789
IRS990ScheduleA/Total509Grp/TotalAmt0286789
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt0295217
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt017915
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0313132
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/CurrentTaxYearAmt0200305
IRS990/ScheduleBRequiredInd0false
IRS990ScheduleD/BuildingsGrp/BookValueAmt02669434
IRS990ScheduleD/BuildingsGrp/DepreciationAmt0619171
IRS990ScheduleD/BuildingsGrp/OtherCostOrOtherBasisAmt03288605
IRS990ScheduleD/LandGrp/BookValueAmt03229805
IRS990ScheduleD/LandGrp/OtherCostOrOtherBasisAmt03229805
IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt013169
IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt0374660
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt0387829
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt016890
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt112925
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt23189
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0TENANT DEPOSITS
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc1OFFICER RELATED LIABILITY
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc2CREDIT CARD/ PAYROLL TAXES
IRS990ScheduleD/TotalBookValueLandBuildingsAmt05912408
IRS990ScheduleD/TotalLiabilityAmt033004
IRS990/ScheduleJRequiredInd0false
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BalanceDueAmt0154516
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BoardOrCommitteeApprovalInd0true
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/DefaultInd0false
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanPurposeTxt0TO AID THE ORGAN TO ACQUIRED INVEST
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanToOrganizationInd0X
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/OriginalPrincipalAmt0154000
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/RelationshipWithOrgTxt0DIRECTOR
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/WrittenAgreementInd0true
IRS990ScheduleL/TotalBalanceDueAmt0154516
IRS990/ScheduleORequiredInd0false
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0FRONTIERS IN BIOSCIENCE IA AN ORGANIZATIOJ DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVO;VE IN THESE ACTIVITIES SINCE JAN. 1 1996. FBS HAS PUBLISHED OBER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND REURRANXCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM OF CANCER CELLS IN ORDER TO GAIN AN INSIGHT TO PROVIDE NEW AVENUES FOR TREATMENT. WE USE STEM CELLS AS WELL AS SIGNALING MOLECULES TO ACHEIVE THE THERAPEUTIC END.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1SEE ATTACHMENT NOVEMBER 20, 2022 PART IV, LINE 63, LOANS FROM OFFICERS, DIRECTOR AND EMPLOYEE ON NOVEMBER 20, 2002, FRONTIERS IN BIOSCIENCE, INC. PURCHASED FOR INVESTMENT PURPOSES ONLY RESIDENTIAL REAL ESTATE LOCATED AT 67 PARKVIEW DRIVE, SEARINGTOWN, NEW YORK. IN CONNECTION WITH THE ORGANIZATION'S PURCHASE OF SAID REAL ESTATE, FRONTIERS IN BIOSCIENCE INC., INCURRED A MORTGAGE PAYABLE WITH THE PRESIDEN AND FOUNDER, SIAMAK TABIBZADEH, MD, IN THE AMOUNT OF 145,000 LENDER'S NAME: SIAMAK TABIBZADEH, MD ORIGINAL AMOUNT OF NOTE: 154,000 BALANCE DUE: 145,555 DATE OF NOTE: NOVEMBER 20, 2002 MATURITY DATE: OPEN, SEE BELOW REPAYMENT TERMS: PRINCIPAL AND ACCRUED INTEREST DUE UPON SALE OF PROPERTY INTEREST RETE: RATE OF 4.5% PER ANNUM, PRINCIPAL AND INTEREST DUE UPON SALE OF PROPERTY OR AT SUCH TIME AS THE BOARD OF DIRECTOR DETERMINES THAT THERE ARE SUFFICIENT OPERATING FUNDS TO RETIRE THE OBILIGATION SECURITY PRIOVIDED BY THE BORROWER: MORTGAGE NOTE SECURED BY REAL ESTATE LOCATED AT 67 PARKVIEW DRIVE, SEARINGTOWN, NY 11507 PURPOSE OF THE LOAN: TO BE ABLE TO PURCHASE REAL ESTATE AT BELOW FAIR MARKET VALUE TO SEE IN NO LONGER THAN TWO OPERATING CYCLES IN ORDER TO OBTAIN SUFFICIENT FUNDING TO ENDOW A FULL TIME MEDICAL RESEARCHER AND EDITOR. INTERST CALCUATION ORIGINAL AMOUNT OF PRINCIPAL: 154,000 FROM TO INTEREST AMOUNT (RATE, 4.5%) - PRINCIPAL + INTEREST NOV 20, 2002 154,000 NOV 20, 2002 NOV 20, 2003 6,930 - 160,930 - 15,375 REMOVED PRINCIPAL & INTEREST LEAVING 145,555 NOV 20, 2003 NOV 20, 2004 6,549 - 152,104 NOV 20, 2004 NOV 20, 2005 6,844 - 158,948 NOV 20, 2005 NOV 20, 2006 7,152 - 166,100 NOV 20, 2006 NOV 20, 2007 7,474 - 173,574 NOV 20, 2007 NOV 20, 2008 7,810 - 181,384 NOV 20, 2008 NOV 20, 2009 8,162 - 189,546 NOV 20, 2009 NOV 20, 2010 8,529 - 198,075 NOV 20, 2010 NOV 20, 2011 8,913 - 206,988 NOV 20, 2011 NOV 20, 2012 9,314 - 216,302 NOV 20, 2012 NOV 20, 2013 9,733 - 226,035 NOV 20, 2013 NOV 20, 2014 10,171 - 236,206 NOV 20, 2014 NOV 20, 2015 10,629 - 257,942 NOV 20, 2015 NOV 20, 2016 11,107 - 246,835 NOV 20, 2016 NOV 20, 2017 11,607 - 269,549 PRINCIPAL PAID 269,549-145,555=123,994 NOV 20, 2017 NOV 20, 2018 5,579 - 129,573 NOV 20, 2018 NOV 20, 2019 5,830 - 135,403 NOV 20, 2019 NOV 20, 2020 6,093 - 141,496 NOV 20, 2020 NOV 20, 2021 6,367 - 147,863 NOV 20, 2021 NOV 20, 2022 6,653 - 154.516
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2NO REVIEW WAS OR WILL BE CONDUCTED.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3NO DOCUMENTS AVAILABLE TO THE PUBLIC
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4ADJUSTMENT TO BEGINNING OF VALUE OF INVESTMENTS -14160
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5BOOK / TAX DEPRECIATION DIFFERENCE 18,532
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990 - ORGANIZATION'S MISSION
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PAGE 6, PART VI, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PAGE 6, PART VI, LINE 19
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PART XI
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5FORM 990, PART XI, LINE 9
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/StatesWhereCopyOfReturnIsFldCd0CA
IRS990/SubjectToExcsTaxNetInvstIncInd0false
IRS990/SubjectToProxyTaxInd0false
IRS990/SubjToTaxRmnrtnExPrchtPymtInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TerminateOperationsInd0false
IRS990/TotalAssetsBOYAmt09154107
IRS990/TotalAssetsEOYAmt09156713
IRS990/TotalAssetsGrp/BOYAmt09154107
IRS990/TotalAssetsGrp/EOYAmt09156713
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt09463
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt034362
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0237534
IRS990/TotalFunctionalExpensesGrp/TotalAmt0281359
IRS990/TotalGrossUBIAmt020776
IRS990/TotalLiabilitiesBOYAmt0192253
IRS990/TotalLiabilitiesEOYAmt0187520
IRS990/TotalLiabilitiesGrp/BOYAmt0192253
IRS990/TotalLiabilitiesGrp/EOYAmt0187520
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt08961854
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt08969193
IRS990/TotalProgramServiceExpensesAmt0237534
IRS990/TotalProgramServiceRevenueAmt0286789
IRS990/TotalReportableCompFromOrgAmt088000
IRS990/TotalRevenueGrp/ExclusionAmt08428
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt0255122
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt0284326
IRS990/TotalRevenueGrp/UnrelatedBusinessRevenueAmt020776
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt09154107
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt09156713
IRS990/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd0true
IRS990/USAddress/AddressLine1Txt020 SUNSET COVE
IRS990/USAddress/CityNm0NEWPORT COAST
IRS990/USAddress/StateAbbreviationCd0CA
IRS990/USAddress/ZIPCd092657
IRS990/VotingMembersGoverningBodyCnt03
IRS990/VotingMembersIndependentCnt00
IRS990/WebsiteAddressTxt0WWW.BIOSCIENCE.ORG
IRS990/WhistleblowerPolicyInd0false
ReturnHeader/BuildTS02022-09-23 18:48:47Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0SIAMAK TABIBZADEH MD
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0CEO
ReturnHeader/BusinessOfficerGrp/PhoneNum09497158286
ReturnHeader/BusinessOfficerGrp/SignatureDt02022-09-02
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0FRONTIERS IN BIOSCIENCE
ReturnHeader/Filer/BusinessNameControlTxt0FRON
ReturnHeader/Filer/EIN0593432665
ReturnHeader/Filer/PhoneNum09497158286
ReturnHeader/Filer/USAddress/AddressLine1Txt020 SUNSET COVE
ReturnHeader/Filer/USAddress/CityNm0NEWPORT COAST
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd092657
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0330990695
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0LGH CONSULTING INC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0585 S STATE COLLEGE BLVD
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0ANAHEIM
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0928064222
ReturnHeader/PreparerPersonGrp/PhoneNum07148089170
ReturnHeader/PreparerPersonGrp/PreparationDt02022-09-23
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0GEORGE HUKRIEDE
ReturnHeader/ReturnTs02022-09-23T17:04:24-04:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm0SIAMAK
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm0TABIBZADEH
ReturnHeader/TaxPeriodBeginDt02021-01-01
ReturnHeader/TaxPeriodEndDt02021-12-31
ReturnHeader/TaxYr02021

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2025Detailed filing. Detailed filing data is available for this year.$8.98$0.25$8.73$0.18$0.39$0.21
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.15$0.24$8.90$0.16$0.33$0.18
2023XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.13$0.25$8.88$0.25$0.26$0.01
2022XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.07$0.18$8.89$0.13$0.27$0.14
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.26$0.19$9.08$0.29$0.24$0.05
2021Detailed filing. Detailed filing data is available for this year.$9.16$0.19$8.97$0.28$0.28$0.00
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.15$0.19$8.96$1.17$0.30$0.87
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$8.33$0.03$8.30$0.67$0.46$0.20
2018XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$8.15$0.03$8.12$0.69$0.47$0.22
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$7.94$0.04$7.90$0.88$0.56$0.32
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$7.72$0.14$7.58$0.69$0.66$0.02
2015Detailed filing. Detailed filing data is available for this year.$7.72$0.16$7.56$0.96$0.57$0.39
2014Detailed filing. Detailed filing data is available for this year.$7.38$0.28$7.10$0.93$0.58$0.35
2013XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$7.02$0.16$6.86$1.02$0.59$0.43
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$6.59$0.16$6.43$0.57
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$6.07$0.15$5.93$0.30